Skip to main content

Table 2 Metabolite changes between each stage of rectal cancers and normal controls

From: ¹H NMR-based metabolic profiling of human rectal cancer tissue

Metabolites

chemical shift

Mutiplicitya

Normal control vs. I

Normal control vs. II

Normal control vs. III

Normal control vs. IV

(ppm)

VIPb

P-valuec

FCd

VIPb

P-valuec

FCd

VIPb

P-valuec

FCd

VIPb

P-valuec

FCd

Myo-inositol

4.06

t

3.04

<0.001

-1.90

3.35

<0.001

-1.93

3.99

<0.001

-2.17

3.16

<0.001

-2.07

 

3.55

dd

2.92

<0.001

-1.95

3.27

<0.001

-1.99

3.89

<0.001

-2.20

3.09

<0.001

-2.08

 

3.63

t

2.35

<0.001

-2.00

2.71

<0.001

-2.04

3.42

<0.001

-2.36

2.80

<0.001

-2.42

Taurine

3.27

t

3.10

<0.001

-2.01

3.37

<0.001

-2.03

3.99

<0.001

-2.28

3.18

<0.001

-2.10

α-Glucose

3.55

dd

2.92

<0.001

-1.95

3.27

<0.001

-1.99

3.89

<0.001

-2.20

3.09

<0.001

-2.08

 

5.23

dd

2.60

<0.001

-4.75

2.81

<0.001

-5.58

3.07

<0.001

-4.57

2.44

<0.001

-4.97

Phosphocreatine

3.93

s

3.02

<0.001

-2.34

3.10

<0.001

-2.07

3.50

<0.001

-2.09

2.91

<0.001

-2.02

 

3.04

s

2.74

<0.001

-2.29

2.94

<0.001

-2.15

3.36

<0.001

-2.16

2.66

<0.001

-1.71

Creatine

3.94

s

3.02

<0.001

-2.34

3.10

<0.001

-2.07

3.50

<0.001

-2.09

2.91

<0.001

-2.02

 

3.04

s

2.74

<0.001

-2.29

2.94

<0.001

-2.15

3.36

<0.001

-2.16

2.66

<0.001

-1.71

Glycolate

3.93

s

3.02

<0.001

-2.34

3.10

<0.001

-2.07

3.50

<0.001

-2.09

2.91

<0.001

-2.02

Betaine

3.89

s

1.97

<0.001

-1.85

2.56

<0.001

-2.10

2.57

<0.001

-1.88

1.88

<0.001

-1.62

Dimethylglycine

3.71

s

2.21

<0.001

-2.58

2.33

<0.001

-2.60

2.39

<0.001

-2.13

1.98

<0.001

-2.22

Glyceryl

4.3

m

2.32

<0.001

-1.48

2.40

<0.001

-1.46

2.59

<0.001

-1.45

1.98

<0.001

-1.38

Lactate

1.33

d

   

1.23

<0.001

1.27

1.84

<0.001

1.26

2.26

<0.001

1.22

 

4.11

q

   

1.13

0.004

1.73

1.52

0.001

1.88

1.52

0.001

2.22

Threonine

1.33

d

0.08

<0.001

1.21

1.23

<0.001

1.27

1.84

<0.001

1.26

2.26

<0.001

1.22

Acetate

1.93

s

      

2.65

<0.001

6.95

1.61

<0.001

2.96

Glutathione

2.56

m

2.49

<0.001

1.62

2.41

<0.001

1.60

2.30

<0.001

1.46

2.35

<0.001

1.81

 

2.96

m

      

1.84

<0.001

1.42

1.50

<0.001

1.39

Uracil

7.54

d

1.99

<0.001

3.04

2.58

<0.001

3.69

2.33

<0.001

2.94

2.33

<0.001

2.46

 

5.8

d

0.91

<0.001

3.06

1.84

<0.001

3.60

2.12

<0.001

3.45

2.19

<0.001

2.67

Succinate

2.41

s

1.05

0.004

1.48

1.15

0.005

1.68

1.93

<0.001

1.75

2.08

<0.001

3.03

O-acetyl glycoprotein

2.07

s

      

2.30

<0.001

2.65

1.30

0.033

1.35

Mannitol

3.69

m

1.31

0.015

-1.20

1.79

<0.001

-1.32

1.53

0.005

-1.23

1.48

<0.001

-1.46

 

3.88

m

1.44

<0.001

-1.31

1.68

<0.001

-1.36

1.37

0.004

-1.25

1.04

0.026

-1.24

Dimethylamine

2.73

s

      

1.24

0.069

1.16

1.97

<0.001

2.32

Leucine

0.96

t

      

1.22

0.004

1.19

1.73

<0.001

1.30

Valine

1.05

d

         

1.47

<0.001

3.29

 

0.99

d

   

1.84

0.011

1.31

1.59

0.023

1.37

1.46

<0.001

1.93

β-hydroxybutyrate

1.2

d

1.10

0.613

-1.07

1.55

<0.001

2.75

2.49

<0.001

2.68

1.27

0.010

1.53

Glutamine

2.14

m

      

1.34

0.0011

1.50

1.43

0.003

1.75

 

3.77

m

   

1.91

<0.001

1.53

1.43

<0.001

1.31

0.87

0.097

1.18

Acetoacetate

2.28

s

         

1.90

<0.001

1.55

Sarcosine

2.75

s

         

1.58

<0.001

2.15

Tyrosine

7.2

d

1.74

0.016

-1.38

1.64

0.012

-1.43

1.42

0.051

-1.28

1.31

0.004

-1.95

 

6.9

d

1.61

0.277

-1.21

1.40

0.275

-1.20

1.29

0.269

-1.21

1.22

0.006

-2.55

Alanine

1.48

d

   

1.69

0.010

1.59

1.59

0.014

1.81

1.00

0.022

2.79

Acetoacetic acid

2.31

s

         

1.77

<0.001

1.60

Serine

3.98

m

1.31

<0.001

1.49

1.93

<0.001

1.56

1.58

<0.001

1.38

1.63

0.004

1.29

Isoleucine

1.01

d

         

1.16

0.006

1.54

 

0.95

t

         

1.46

0.019

1.21

Trimethylamine-N-oxide

3.27

s

   

1.60

<0.001

3.59

1.23

<0.001

2.73

1.67

0.008

2.09

Lysine

3.77

m

   

1.91

<0.001

1.53

1.43

<0.001

1.31

   

Acetone

2.23

s

         

1.34

0.003

1.49

PC(phosphochline)

3.21

s

   

1.68

<0.001

1.31

1.13

0.017

1.19

1.40

0.003

1.22

GPC(glycerophosphochline)

3.23

s

2.00

<0.001

1.49

1.75

<0.001

1.51

1.14

0.002

1.26

1.92

<0.001

1.35

NAD

8.83

d

         

1.05

0.015

3.25

 

9.15

d

         

1.55

<0.001

1.97

2-Hydroxyisobutyric acid

1.44

s

1.00

0.018

-1.18

1.17

0.007

-1.22

1.23

0.012

-1.20

   

Trytophan

7.29

m

1.35

0.012

-1.32

1.75

<0.001

-1.50

      

Formic acid

8.44

s

         

1.53

<0.001

1.93

  1. aMultiplicity: s singlet, d doublet, t triplet, q quartet, dd doublet of doublets, m multiplet.
  2. bVariable importance in the projection was obtained from OPLS-DA model with a threshold of 1.0.
  3. cp-value obtained from Student’s t-test.
  4. dFold change(FC) between rectal cancers and normal controls. Fold change with a positive value indicates a relatively higher concentration present in rectal cancer patients while a negative value means a relatively lower concentration as compared to the normal controls.